 |
| |||
 | ||||
 |
| ||||||
 | |||||||
2007 SWAF, EAC, and TAAIS Combined Meeting on Allergy, Asthma and Immunology, Jointly Sponsored and Accredited for 20 CME and 24 CE Hours by the AAAAI.
January 17-21, 2007
Fiesta Americana Puerto Vallarta, Puerto Vallarta, Mexico.
Wednesday, January 17, 2007
Pre-Conference Symposium
Asthma Health Management in 2007: Assessing the Risk-Benefit Ratio of Therapy
Moderator: Joseph Bellanti, M.D.
5:00-5:45 The Safety of LABA Therapy in Persistent Asthma: Where Do We
Go From Here?
Lyndon Mansfield, M.D.
5:45-6:30 Addressing Steroid Phobia: Improving the Risk-Benefit Ratio with New Agents
David Skoner, M.D.
6:30-7:00 Panel Discussion: Q & A
Thursday, January 18, 2007
Eastern Allergy Conference Section
Moderator: Michael Slaughter, M.D.
8:00-8:40 Immunotherapy: When to Initiate Treatment in Children?
Ira Finegold, M.D.
8:40-9:20 New Advances in Clinically Relevant Immunology
Joseph Bellanti, M.D.
9:20-10:00 Diagnosis and Treatment of Chronic Eosinophilic Rhinosinusitis
BJ Ferguson, M.D.
10:00-10:15 Panel Discussion: Q & A
10:15-10:45 Coffee Break
10:45-11:45 PBL Case: Food Allergy
Ray Davis, M.D., Russell Settipane, M.D., Christine Wagner, RN, MSN,
Don Fournier, M.D., and Phil Lieberman, M.D.
11:45-12:25 Optimal Choices for Food Challenge Testing
Sami Bahna, M.D.
12:25-1:05 Benchmarking the Business Aspects of Allergy Practice
Marshall Grodofsky, M.D.
1:05-1:30 Panel Discussion: Q & A
Symposium
Children Under the Influence: The Impact of Suboptimal Treatment
for Seasonal Allergic Rhinitis and Chronic Idiopathic Urticaria
Funded through an unrestricted educational grant from Sanofi-Aventis Pharmaceuticals and
organized by Allergy & Asthma Proceedings.
5:00-5:45 The Impact of Suboptimal Treatment for SAR and CIU in School Children
Craig Jones, M.D.
5:45-6:30 Treating SAR and CIU with Antihistamines in the Pediatric Population
Achieving Optimal Outcomes
David Skoner, M.D.
6:30-7:00 Panel Discussion: Q & A
Friday, January 19, 2007
Texas Allergy, Asthma and Immunology Society Section
Moderator: Donald Fournier, M.D.
8:00-8:40 Early Experience with Omalizumab in Clinical Research
William Lumry, M.D.
8:40-9:20 Use of Omalizumab in ABPA and Other off Label Conditions
Raymond Slavin, M.D.
9:20-10:00 Similar Mechanisms in Rhinitis and Asthma
Phil Lieberman, M.D.
10:00-10:15 Panel Discussion: Q & A
10:15-10:45 Coffee Break
10:45-11:25 What is a Hypoallergenic Infant Formula?
Sami Bahna, M.D.
11:25-12:05 Heredity Angioedema (HAE) Update: What Newer Medications are
on the Horizon
William Lumry, M.D.
12:05-12:45 Is Theophylline Still Around?
Laura Somerville, M.D.
12:45-1:30 Box Lunch Program for Attendees: Funded by ALK-Abello
What's in that Vial? Allergen Scientific Advancement
Greg Plunkett, Ph.D.
1:30-1:45 Panel Discussion: Q & A
Saturday, January 20, 2007
Southwest Allergy Forum Section
Moderator: Kurt Peters, M.D.
8:00-8:40 Dendritic Cells and Their Role in Allergy
Andy Liu, M.D.
8:40-9:20 Are Mast Cells Still Important?
Edward Schulman, M.D.
9:20-10:00 Is Innate Immunity What It’s All About?
David Broide, M.D.
10:00-10:15 Panel Discussion: Q & A
10:15-10:45 Coffee Break
10:45-11:25 Thirty Years of Some Strange IGE-Related Allergies I Have Encountered
Raymond Slavin, M.D.
11:25-12:05 Does Exhaled Nitric Oxide Evaluation Have a Future in Your Practice?
Andy Liu, M.D.
12:05-12:45 Anaphylaxis, Myths and Facts
Phil Lieberman, M.D.
12:45-1:00 Panel Discussion: Q & A
Sunday, January 21, 2007
Assessing and Meeting the Needs in Allergic Rhinoconjunctivitis
Moderator: Clifford Tepper, M.D.
Funded through an unrestricted educational grant from Alcon Laboratories and organized by
Allergy & Asthma Proceedings.
8:30-9:00 Allergic Rhinoconjunctivitis: Burden of Disease
Michael Blaiss, M.D.
9:00-9:30 Pathophysiology of Allergic Rhinoconjunctivitis
David Broide, M.D.
9:30-10:00 Therapy of Allergic Rhinoconjunctivitis
Todd Mahr, M.D.
10:00-10:30 Panel Discussion: Q & A
10:30 Adjourn until 2008
